Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 10-15 , January 2008

Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

  • David Gómez-Almaguer

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
    • Corresponding Author InformationCorrespondence and reprint requests: David Gómez-Almaguer, MD, Hematology Department, University Hospital, UANL, Av. Madero y Gonzalitos s/n, Col. Mitras Centro CP 64460, Monterrey, NL, México.
  • ,
  • Guillermo J. Ruiz-Argüelles

      Affiliations

    • Centro de Hematología y Medicina Interna de Puebla, Puebla, México
  • ,
  • Luz del Carmen Tarín-Arzaga

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
  • ,
  • Oscar González-Llano

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
  • ,
  • Homero Gutiérrez-Aguirre

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
  • ,
  • Olga Cantú-Rodríguez

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
  • ,
  • José Jaime-Pérez

      Affiliations

    • Servicio de Hematología, Hospital Universitario “Dr. José E. González,” Universidad Autónoma Nuevo León, Monterrey, NL, México
  • ,
  • Antonio Carrasco-Yalán

      Affiliations

    • Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
  • ,
  • Sergio Giralt

      Affiliations

    • M.D. Anderson Cancer Center, Houston, Texas

Received 23 August 2007 ,Accepted 16 October 2007.

  • Image Result

    Kaplan-Meier plot of overall survival based on response to alemtuzumab therapy.

    Kaplan-Meier plot of overall survival based on response to alemtuzumab therapy.

PII: S1083-8791(07)00510-1

doi: 10.1016/j.bbmt.2007.08.052

Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 10-15 , January 2008